Browse Neurology Articles by Topic

Statins Associated with Lower Parkinson’s Risk in Diabetics

In approximately 50,000 individuals with Parkinson’s disease and diabetes, identified from a National Health Insurance database in Taiwan, statin use was dose-dependently associated with lower risk of Parkinson’s disease. This strengthens the argument for a possible protective role of statins.

Intravenous Glyburide to Reduce Brain Swelling in Large Hemispheric Infarction

In a Phase II, randomized, multicenter prospective trial, intravenous glyburide failed to improve outcomes in patients with large hemispheric infarction, although there was a reduction in neuroimaging and biomarkers of cerebral edema.

RESCUEicp: A Trial of Decompressive Craniectomy for Traumatic Intracranial Hypertension

Decompressive craniectomy for the treatment of refractory intracranial hypertension in patients with severe traumatic brain injury reduced mortality but increased rates of vegetative states, lower severe disability, and upper severe disability compared to continued medical management.

Clinical Briefs

In this section: improving CPAP adherence; drug therapy for type 2 diabetes; and correcting inhaler techniques.

Aspirin and Omeprazole Delayed-release Tablets (Yosprala)

The combination is indicated for patients who require aspirin for secondary prevention of cardiovascular and cerebrovascular events and who are at risk of aspirin-associated gastric ulcers.

Headaches in the Elderly: A Non-specific Marker for Stroke Risk

Non-migrainous headaches, for which there are many causes, appear to be a risk factor for stroke in an elderly population, but the mechanism is uncertain.

The Growing Threat of Pyelonephritis Caused by Antibiotic-resistant Escherichia coli

In patients with acute pyelonephritis due to Escherichia coli presenting to one of 10 EDs, the prevalence of fluoroquinolone resistance ranged from 6.3% to 19.9%, and the prevalence of extended-spectrum beta-lactamase production was 2.6% to 12.2%.

Effects of Aspirin on Risk of Early Recurrent Stroke After Transient Ischemic Attack and Ischemic Stroke

Aspirin administered early after the onset of transient ischemic attack symptoms substantially reduces the risk of developing a stroke.

Ticagrelor vs. Aspirin: Post-TIA and Stroke

The first 90 days after a transient ischemic attack or ischemic stroke is a high-risk period for recurrence of cardiovascular thrombotic events. Even with aspirin treatment, recurrences occur in as many as 10-15% of patients.

Heart Failure with Recovered Ejection Fraction: A Distinct Phenotype

SYNOPSIS: Patients suffering from systolic heart failure who subsequently improve their ejection fraction experience a more favorable clinical course compared to those presenting with persistently reduced ejection fraction or heart failure with preserved ejection fraction.